Cargando…
Trial Watch: DNA vaccines for cancer therapy
During the past 2 decades, the possibility that preparations capable of eliciting tumor-specific immune responses would mediate robust therapeutic effects in cancer patients has received renovated interest. In this context, several approaches to vaccinate cancer patients against their own malignanci...
Autores principales: | Pol, Jonathan, Bloy, Norma, Obrist, Florine, Eggermont, Alexander, Galon, Jérôme, Hervé Fridman, Wolf, Cremer, Isabelle, Zitvogel, Laurence, Kroemer, Guido, Galluzzi, Lorenzo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Landes Bioscience
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4008456/ https://www.ncbi.nlm.nih.gov/pubmed/24800178 http://dx.doi.org/10.4161/onci.28185 |
Ejemplares similares
-
Trial Watch:: Oncolytic viruses for cancer therapy
por: Pol, Jonathan, et al.
Publicado: (2014) -
Trial Watch: Peptide-based anticancer vaccines
por: Pol, Jonathan, et al.
Publicado: (2015) -
Trial Watch: Adoptive cell transfer for anticancer immunotherapy
por: Aranda, Fernando, et al.
Publicado: (2014) -
Trial watch: Immunostimulatory cytokines in cancer therapy
por: Vacchelli, Erika, et al.
Publicado: (2014) -
Trial watch: DNA vaccines for cancer therapy
por: Senovilla, Laura, et al.
Publicado: (2013)